ArticleNAR cancer2023

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation.

Alan Van Goethem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.